LifeStory Health, Inc. is currently enrolling patients for their clinical trial: Screening of Cancer Through Novel Female Specific Biomarkers.  Clinical trial recruitment is being conducted across multiple sites in Central Texas with LSH’s trial partner, Baylor Scott and White Hospital System (BSW), the largest non-profit healthcare system in Texas and one of the largest in the country.

A second research study is anticipated to begin Early 2020 and recruitment will extend worldwide. Each participant will receive a health product gift bag for their involvement in the study. Please email for more information on how to get involved.

In today’s world, many latent cancers are female-prevalent cancers, where early-stage detection is rare and a devastating late-stage diagnosis is the norm.  Our technology platform indicates that menstrual blood is rich with information that can lead to the very early-detection that so many female patients and physicians hope for in order to diagnose and treat cancer at a time when it is curable or when the treatment plan is far less intensive and intrusive.

We also believe that, based on our 2016 and 2018 research studies, our novel technology can lead to improved drug discovery and trial recruitment, thus equalizing the known gender parities in today’s drug development process.